• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation.单体阿尔茨海默病淀粉样β肽中β-发夹结构的稳定化抑制淀粉样蛋白形成。
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5099-104. doi: 10.1073/pnas.0711731105. Epub 2008 Mar 28.
2
The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.富勒烯衍生物对淀粉样β肽聚集的抑制机制:一项原子模拟研究。
Phys Chem Chem Phys. 2016 May 14;18(18):12582-91. doi: 10.1039/c6cp01014h. Epub 2016 Apr 19.
3
α-synuclein-assisted oligomerization of β-amyloid (1-42).α-突触核蛋白辅助β-淀粉样蛋白(1-42)的寡聚化。
Arch Biochem Biophys. 2022 Mar 15;717:109120. doi: 10.1016/j.abb.2022.109120. Epub 2022 Jan 15.
4
Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.阿尔茨海默病β-淀粉样蛋白(1-40)肽的两种膜相互作用:防止聚集的跨膜锚定与加速表面原纤维形成。
J Mol Biol. 2004 Jan 23;335(4):1039-49. doi: 10.1016/j.jmb.2003.11.046.
5
Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.利用噬菌体展示技术体外鉴定特异性结合β-淀粉样蛋白1-40以及阿尔茨海默病大脑中淀粉样斑块的肽段。
Neurobiol Dis. 2003 Oct;14(1):146-56. doi: 10.1016/s0969-9961(03)00105-0.
6
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.焦谷氨酸化淀粉样β的朊样行为和tau 依赖性细胞毒性。
Nature. 2012 May 2;485(7400):651-5. doi: 10.1038/nature11060.
7
Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.阿尔茨海默病:来自溶液核磁共振和圆二色性研究的膜模拟环境中的可溶性寡聚β淀粉样蛋白(1-40)肽
Neurochem Res. 2004 Dec;29(12):2267-72. doi: 10.1007/s11064-004-7035-1.
8
Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.通过蛋白质工程稳定神经毒性阿尔茨海默病淀粉样β寡聚体。
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15595-600. doi: 10.1073/pnas.1001740107. Epub 2010 Aug 16.
9
Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.家族性阿尔茨海默病突变(D7H、D7N和H6R)对淀粉样β肽的双重影响:关联动力学与锌结合
Proteins. 2014 Dec;82(12):3286-97. doi: 10.1002/prot.24669. Epub 2014 Oct 21.
10
In silico and in vitro studies to elucidate the role of Cu2+ and galanthamine as the limiting step in the amyloid beta (1-42) fibrillation process.通过计算机模拟和体外研究来阐明 Cu2+ 和加兰他敏在淀粉样β(1-42)纤维形成过程中的作用。
Protein Sci. 2013 Oct;22(10):1320-35. doi: 10.1002/pro.2319. Epub 2013 Aug 19.

引用本文的文献

1
A genetically encoded selection for amyloid-β oligomer binders.一种针对淀粉样β寡聚体结合剂的基因编码筛选方法。
Nat Chem Biol. 2025 Jul 15. doi: 10.1038/s41589-025-01975-4.
2
Chameleonic Nature of Aβ: Implications for Alzheimer's and Other Amyloid Diseases.Aβ的变色龙特性:对阿尔茨海默病及其他淀粉样疾病的影响
Bioessays. 2025 Sep;47(9):e70039. doi: 10.1002/bies.70039. Epub 2025 Jul 11.
3
Inhibitory mechanisms of amentoflavone on amyloid-β peptide aggregation revealed by replica exchange molecular dynamics.通过副本交换分子动力学揭示穗花杉双黄酮对淀粉样β肽聚集的抑制机制
Sci Rep. 2025 Jul 8;15(1):24352. doi: 10.1038/s41598-025-10623-9.
4
Diversity of Aβ aggregates produced in a gut-based Drosophila model of Alzheimer's disease.在基于肠道的阿尔茨海默病果蝇模型中产生的β淀粉样蛋白聚集体的多样性。
PLoS One. 2025 Jul 8;20(7):e0314832. doi: 10.1371/journal.pone.0314832. eCollection 2025.
5
An Anti-BCMA Affibody Affinity Protein for Therapeutic and Diagnostic Use in Multiple Myeloma.一种用于多发性骨髓瘤治疗和诊断的抗BCMA亲合体亲和蛋白。
Int J Mol Sci. 2025 May 28;26(11):5186. doi: 10.3390/ijms26115186.
6
Engineered sequestrins inhibit aggregation of pathogenic alpha-synuclein mutants.工程化的隔离蛋白抑制致病性α-突触核蛋白突变体的聚集。
Front Immunol. 2025 May 16;16:1574755. doi: 10.3389/fimmu.2025.1574755. eCollection 2025.
7
Formation of a β-Endorphin Corona Mitigates Alzheimer's Amyloidogenesis.β-内啡肽晕圈的形成减轻阿尔茨海默病的淀粉样蛋白生成。
Small. 2025 Jul;21(26):e2409392. doi: 10.1002/smll.202409392. Epub 2025 May 19.
8
A β-hairpin peptide derived from Aβ forms different oligomers in the crystal state and in aqueous solution.一种源自β淀粉样蛋白(Aβ)的β发夹肽在晶体状态和水溶液中形成不同的寡聚体。
Org Biomol Chem. 2025 Apr 16;23(16):3881-3893. doi: 10.1039/d5ob00296f.
9
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology.神经退行性疾病中的靶向药物递送:纳米技术的作用
Front Med (Lausanne). 2025 Jan 29;12:1522223. doi: 10.3389/fmed.2025.1522223. eCollection 2025.
10
Molecular Simulation of the Binding of Amyloid Beta to Apolipoprotein A-I in High-Density Lipoproteins.高密度脂蛋白中β淀粉样蛋白与载脂蛋白A-I结合的分子模拟
Int J Mol Sci. 2025 Feb 6;26(3):1380. doi: 10.3390/ijms26031380.

本文引用的文献

1
Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils.通过稳定β-淀粉样蛋白原纤维来阻止成熟淀粉样纤维形成的构象抗体结构域的定向筛选。
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19232-7. doi: 10.1073/pnas.0703793104. Epub 2007 Nov 27.
2
Molecular basis for passive immunotherapy of Alzheimer's disease.阿尔茨海默病被动免疫疗法的分子基础。
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15659-64. doi: 10.1073/pnas.0705888104. Epub 2007 Sep 25.
3
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.使用¹⁷⁷Lu标记的HER2特异性亲和体分子对HER2阳性微小异种移植瘤进行放射性核素治疗。
Cancer Res. 2007 Mar 15;67(6):2773-82. doi: 10.1158/0008-5472.CAN-06-1630.
4
A beta oligomers - a decade of discovery.β-寡聚体——十年探索历程
J Neurochem. 2007 Jun;101(5):1172-84. doi: 10.1111/j.1471-4159.2006.04426.x. Epub 2007 Feb 5.
5
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.神经退行性变中的可溶性蛋白质寡聚体:来自阿尔茨海默病淀粉样β肽的启示
Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12. doi: 10.1038/nrm2101.
6
Plasticity of amyloid fibrils.淀粉样纤维的可塑性。
Biochemistry. 2007 Jan 9;46(1):1-10. doi: 10.1021/bi0620959.
7
Inhibition of beta-amyloid fibrillization by directed evolution of a beta-sheet presenting miniature protein.通过定向进化呈现β-折叠的微型蛋白质抑制β-淀粉样蛋白纤维化
J Am Chem Soc. 2006 Nov 15;128(45):14456-7. doi: 10.1021/ja065557e.
8
Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.与阿尔茨海默病淀粉样β肽结合的亲合体配体的筛选与表征
J Biotechnol. 2007 Jan 30;128(1):162-83. doi: 10.1016/j.jbiotec.2006.09.013. Epub 2006 Sep 27.
9
A century-old debate on protein aggregation and neurodegeneration enters the clinic.一场关于蛋白质聚集与神经退行性变的百年争论进入了临床阶段。
Nature. 2006 Oct 19;443(7113):774-9. doi: 10.1038/nature05290.
10
Peptide-based inhibitors of amyloid assembly.基于肽的淀粉样蛋白组装抑制剂。
Methods Enzymol. 2006;413:273-312. doi: 10.1016/S0076-6879(06)13015-3.

单体阿尔茨海默病淀粉样β肽中β-发夹结构的稳定化抑制淀粉样蛋白形成。

Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation.

作者信息

Hoyer Wolfgang, Grönwall Caroline, Jonsson Andreas, Ståhl Stefan, Härd Torleif

机构信息

Department of Medical Biochemistry and Swedish Nuclear Magnetic Resonance Center, University of Gothenburg, Box 440, SE-405 30 Göteborg, Sweden.

出版信息

Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5099-104. doi: 10.1073/pnas.0711731105. Epub 2008 Mar 28.

DOI:10.1073/pnas.0711731105
PMID:18375754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2278213/
Abstract

According to the amyloid hypothesis, the pathogenesis of Alzheimer's disease is triggered by the oligomerization and aggregation of the amyloid-beta (Abeta) peptide into protein plaques. Formation of the potentially toxic oligomeric and fibrillar Abeta assemblies is accompanied by a conformational change toward a high content of beta-structure. Here, we report the solution structure of Abeta(1-40) in complex with the phage-display selected affibody protein Z(Abeta3), a binding protein of nanomolar affinity. Bound Abeta(1-40) features a beta-hairpin comprising residues 17-36, providing the first high-resolution structure of Abeta in beta conformation. The positions of the secondary structure elements strongly resemble those observed for fibrillar Abeta. Z(Abeta3) stabilizes the beta-sheet by extending it intermolecularly and by burying both of the mostly nonpolar faces of the Abeta hairpin within a large hydrophobic tunnel-like cavity. Consequently, Z(Abeta3) acts as a stoichiometric inhibitor of Abeta fibrillation. The selected Abeta conformation allows us to suggest a structural mechanism for amyloid formation based on soluble oligomeric hairpin intermediates.

摘要

根据淀粉样蛋白假说,阿尔茨海默病的发病机制是由β淀粉样蛋白(Aβ)肽寡聚化并聚集成蛋白斑块所引发的。具有潜在毒性的寡聚体和纤维状Aβ聚集体的形成伴随着向高含量β结构的构象变化。在此,我们报道了与噬菌体展示筛选出的亲和体蛋白Z(Aβ3)(一种具有纳摩尔亲和力的结合蛋白)结合的Aβ(1-40)的溶液结构。结合的Aβ(1-40)具有一个由17至36位残基组成的β发夹结构,提供了处于β构象的Aβ的首个高分辨率结构。二级结构元件的位置与在纤维状Aβ中观察到的位置非常相似。Z(Aβ3)通过分子间扩展β折叠并将Aβ发夹结构的两个主要非极性面掩埋在一个大的疏水隧道样腔体内来稳定β折叠。因此,Z(Aβ3)作为Aβ纤维化的化学计量抑制剂发挥作用。所选择的Aβ构象使我们能够基于可溶性寡聚发夹中间体提出一种淀粉样蛋白形成的结构机制。